Home › Funds › Deep Track Capital, LP › CRVS

Deep Track Capital, LP position in CRVS

CORVUS PHARMACEUTICALS INC · Health Care

Deep Track Capital, LP reported holding 2,491,939 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$28.7M, representing 0.48% of its reported portfolio and ranking #47 among its reported holdings. Deep Track Capital, LP has disclosed CRVS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)2.49M sh
Reported value held$28.71M
Portfolio Weight0.48%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's CRVS position evolved

Deep Track Capital, LP first disclosed a stake in CRVS in Q1 2026 at 2,491,539 shares (US$36.5M). The position peaked in Q2 2026 at 2,491,939 shares, worth US$37.2M. Across 3 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,491,939 shares valued at US$28.7M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.49M $36.45M New
Q2 2026 2.49M $37.23M Hold
Q3 2026 2.49M $28.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRVS and 13F data

CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), PERCEPTIVE ADVISORS LLC (US$39.9M), ADAMS STREET PARTNERS LLC (US$37.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRVS

All CRVS fund holders →

FAQ

How long has Deep Track Capital, LP held CRVS?

Deep Track Capital, LP has disclosed CRVS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Deep Track Capital, LP's current position in CRVS?

As of Q3 2026, Deep Track Capital, LP holds 2.49M shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $28.71M, representing 0.48% of its reported portfolio and ranking #47.

Has Deep Track Capital, LP been buying or selling CRVS?

In the latest 13F filing (Q3 2026), Deep Track Capital, LP held unchanged its position in CRVS. The position peaked in Q2 2026 at 2.49M shares.

Which other funds hold CRVS?

Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, ADAMS STREET PARTNERS LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.